Incidence and Predictors of Hypertension Among HIV Patients Receiving ART at Public Health Facilities, Northwest Ethiopia: A One-Year Multicenter Prospective Follow-Up Study

References

• World Health Organization. HIV/AIDS: Global Situation and Trends. Global Health Observatory; 2013.
   Google Scholar
• Piot P, Bartos M, Ghys PD, Walker N, Schwartländer B. The global impact of HIV/AIDS. Nature. 2001;410(6831):968. doi:10.1038/35073639
   PubMed Web of Science ®Google Scholar
• De Cock KM, Weiss HA. The global epidemiology of HIV/AIDS. Trop Med Int Health. 2000;5(7):A3–A9. doi:10.1046/j.1365-3156.2000.00590.x
   Web of Science ®Google Scholar
• Mulugeta H, Dessie G, Wagnew F, Jara D, Leshargie CT, Negesse A. Seroprevalence and trend of human immunodeficiency virus among blood donors in Ethiopia: a systematic review and meta-analysis. BMC Infect Dis. 2019;19(1):383. doi:10.1186/s12879-019-4012-5
   Web of Science ®Google Scholar
• World Health Organization. Global Health Sector Response to HIV, 2000–2015: Focus on Innovations in Africa: Progress Report. World Health Organization; 2015.
   Google Scholar
• Currier JS, Lundgren JD, Carr A, et al.; Working Group 2. Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active anti-retroviral therapy. Circulation. 2008;118(2):e29–e35. doi:10.1161/CIRCULATIONAHA.107.189624
   PubMedGoogle Scholar
• Barnes RP, Lacson JCA, Bahrami H. HIV infection and risk of cardiovascular diseases beyond coronary artery disease. Curr Atheroscler Rep. 2017;19(5):20. doi:10.1007/s11883-017-0652-3
   PubMed Web of Science ®Google Scholar
• McDonald CL, Kaltman JR. Cardiovascular disease in adult and pediatric HIV/AIDS. J Am Coll Cardiol. 2009;54(13):1185–1188. doi:10.1016/j.jacc.2009.05.055
   Web of Science ®Google Scholar
• Palacios R, Santos J, Garcia A, et al. Impact of highly active anti-retroviral therapy on blood pressure in HIV‐infected patients. A prospective study in a cohort of naive patients. HIV Med. 2006;7(1):10–15. doi:10.1111/j.1468-1293.2005.00333.x
   PubMed Web of Science ®Google Scholar
• Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV. Causes of death among persons with AIDS in the era of highly active anti-retroviral therapy: New York City. Ann Intern Med. 2006;145(6):397–406. doi:10.7326/0003-4819-145-6-200609190-00003
   PubMed Web of Science ®Google Scholar
• Schouten J, Wit FW, Stolte IG, et al. Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. Clin Infect Dis. 2014;59(12):1787–1797. doi:10.1093/cid/ciu701
   PubMed Web of Science ®Google Scholar
• Gazzaruso C, Bruno R, Garzaniti A, et al. Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome. J Hypertens. 2003;21(7):1377–1382. doi:10.1097/00004872-200307000-00028
   PubMed Web of Science ®Google Scholar
• World Health Organization. Noncommunicable Diseases Progress Monitor 2015. World Health Organization; 2015.
   Google Scholar
• Nguyen KA, Peer N, Mills EJ, Kengne AP. Burden, determinants, and pharmacological management of hypertension in HIV-positive patients and populations: a systematic narrative review. AIDS Rev. 2015;17(2):83–95.
   PubMed Web of Science ®Google Scholar
• Montaner JS, Lima VD, Barrios R, et al. Expanded HAART coverage is associated with decreased population-level HIV-1-RNA and annual new HIV diagnoses in British Columbia, Canada. Lancet. 2010;376(9740):532. doi:10.1016/S0140-6736(10)60936-1
   PubMed Web of Science ®Google Scholar
• Morison L. The global epidemiology of HIV/AIDS. Br Med Bull. 2001;58(1):7–18. doi:10.1093/bmb/58.1.7
   PubMed Web of Science ®Google Scholar
• Kim J, Bang JH, Shin J-Y, Yang BR, Lee J, Park B-J. Hypertension risk with abacavir use among HIV-infected individuals: a Nationwide Cohort Study. Yonsei Med J. 2018;59(10):1245–1252. doi:10.3349/ymj.2018.59.10.1245
   Web of Science ®Google Scholar
• Thiébaut R, El-Sadr WM, Friis-Moller N, et al. Predictors of hypertension and changes of blood pressure in HIV-infected patients. Antivir Ther. 2005;10(7):811.
   PubMed Web of Science ®Google Scholar
• Krauskopf K, Natta MLV, Danis RP, et al. Correlates of hypertension in patients with AIDS in the era of highly active anti-retroviral therapy. J Int Assoc Provid AIDS Care. 2013;12(5):325–333. doi:10.1177/2325957413491432
   Google Scholar
• Brennan AT, Jamieson L, Crowther NJ, et al. Prevalence, incidence, predictors, treatment, and control of hypertension among HIV-positive adults on anti-retroviral treatment in public sector treatment programs in South Africa. PLoS One. 2018;13(10):e0204020. doi:10.1371/journal.pone.0204020
   Web of Science ®Google Scholar
• Okello S, Kanyesigye M, Muyindike WR, et al. Incidence and predictors of hypertension in adults with HIV initiating anti-retroviral therapy in Southwestern Uganda. J Hypertens. 2015;33(10):2039. doi:10.1097/HJH.0000000000000657
   PubMed Web of Science ®Google Scholar
• Hsue PY, Deeks SG, Hunt PW. Immunologic basis of cardiovascular disease in HIV-infected adults. J Infect Dis. 2012;205(suppl_3):S375–S382. doi:10.1093/infdis/jis200
   Web of Science ®Google Scholar
• Mateen FJ, Kanters S, Kalyesubula R, et al. Hypertension prevalence and Framingham risk score stratification in a large HIV-positive cohort in Uganda. J Hypertens. 2013;31(7):1372–1378. doi:10.1097/HJH.0b013e328360de1c
   PubMed Web of Science ®Google Scholar
• Cahn P, Leite O, Rosales A, et al. Metabolic profile and cardiovascular risk factors among Latin American HIV-infected patients receiving HAART. Braz J Infect Dis. 2010;14(2):158–166. doi:10.1016/S1413-8670(10)70030-1
   Web of Science ®Google Scholar
• Kannel WB. Risk factors in hypertension. J Cardiovasc Pharmacol. 1989;13:S4–10. doi:10.1097/00005344-198900131-00003
   PubMed Web of Science ®Google Scholar
• American Heart Association. What is High Blood Pressure? South Carolina State Documents Depository; 2017.
   Google Scholar
• Rodríguez-Arbolí E, Mwamelo K, Kalinjuma AV, et al. Incidence and risk factors for hypertension among HIV patients in rural Tanzania–A prospective cohort study. PLoS One. 2017;12(3):e0172089. doi:10.1371/journal.pone.0172089
   Web of Science ®Google Scholar
• Wong C, Gange SJ, Buchacz K, et al. First occurrence of diabetes, chronic kidney disease, and hypertension among North American HIV-infected Adults, 2000–2013. Clin Infect Dis. 2017;64(4):459–467.
   PubMed Web of Science ®Google Scholar
• Fan H, Guo F, Hsieh E, et al. Incidence of hypertension among persons living with HIV in China: a multicenter cohort study. BMC Public Health. 2020;20(1):1–11. doi:10.1186/s12889-020-08586-9
   PubMed Web of Science ®Google Scholar
• Everett B, Zajacova A. Gender differences in hypertension and hypertension awareness among young adults. Biodemography Soc Biol. 2015;61(1):1–17. doi:10.1080/19485565.2014.929488
   PubMed Web of Science ®Google Scholar
• Berhane T, Yami A, Alemseged F, et al. Prevalence of lipodystrophy and metabolic syndrome among HIV positive individuals on Highly Active Anti-Retroviral treatment in Jimma, South West Ethiopia. Pan Afri Med J. 2012;13(1).
   Google Scholar
• Avolio A, Deng F-Q, Li W-Q, et al. Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China. Circulation. 1985;71(2):202–210. doi:10.1161/01.CIR.71.2.202
   PubMed Web of Science ®Google Scholar
• Krauskopf K, Van natta ML, Danis RP, et al. Correlates of hypertension in patients with AIDS in the era of highly active anti-retroviral therapy. J Int Assoc Provid AIDS Care. 2013;12(5):325–333.
   Google Scholar
• Epstein M, Sowers JR. Diabetes mellitus and hypertension. Hypertension. 1992;19(5):403–418. doi:10.1161/01.HYP.19.5.403
   PubMed Web of Science ®Google Scholar
• Pangmekeh PJ, Awolu MM, Gustave S, Gladys T, Cumber SN. Association between highly active anti-retroviral therapy (HAART) and hypertension in persons living with HIV/AIDS at the Bamenda regional hospital, Cameroon. Pan Afr Med J. 2019;33. doi:10.11604/pamj.2019.33.87.15574
   Web of Science ®Google Scholar
• de Arruda Junior ER, Lacerda HR, Moura LCRV, et al. Risk factors related to hypertension among patients in a cohort living with HIV/AIDS. Braz J Infect Dis. 2010;14(3):281–287. doi:10.1016/S1413-8670(10)70057-X
   PubMed Web of Science ®Google Scholar
• Ruga E, Bova S, Nussdorfer G, et al. Zidovudine-induced alterations in the heart and vascular smooth muscle of the rat. Cardiovasc Res. 2003;60(1):147–155. doi:10.1016/S0008-6363(03)00364-X
   Web of Science ®Google Scholar
• Remais JV, Zeng G, Li G, Tian L, Engelgau MM. Convergence of non-communicable and infectious diseases in low-and middle-income countries. Int J Epidemiol. 2012;42(1):221–227. doi:10.1093/ije/dys135
   Web of Science ®Google Scholar
• Vecchiet J, Ucciferri C, Falasca K, Mancino P, Di Iorio A, De Caterina R. Antihypertensive and metabolic effects of telmisartan in hypertensive HIV-positive patients. Antivir Ther. 2011;16(5):639. doi:10.3851/IMP1809
   Web of Science ®Google Scholar
• Patel P, Speight C, Maida A, et al. Integrating HIV and hypertension management in low-resource settings: lessons from Malawi. PLoS Med. 2018;15(3):e1002523. doi:10.1371/journal.pmed.1002523
   PubMed Web of Science ®Google Scholar
• Pereira M, Lunet N, Paulo C, Severo M, Azevedo A, Barros H. Incidence of hypertension in a prospective cohort study of adults from Porto, Portugal. BMC Cardiovasc Disord. 2012;12(1):1–8. doi:10.1186/1471-2261-12-114
   Web of Science ®Google Scholar
• Stein JH, Hadigan CM, Brown TT, et al. Prevention strategies for cardiovascular disease in HIV-infected patients. Circulation. 2008;118(2):e54–e60. doi:10.1161/CIRCULATIONAHA.107.189628
   Google Scholar